Production of false-positive immunoglobulin M antibodies to Hepatitis A virus in autoimmune events

Journal of Infectious Diseases

Volumn 213, Issue 2, 2016, Pages 324-325

  Tennant, Elaine ^a   Post, Jeffrey J ^a,b  

^a PRINCE OF WALES HOSPITAL   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ANTINUCLEAR ANTIBODY; ASPARTATE AMINOTRANSFERASE; AZATHIOPRINE; BILIRUBIN; COCODAMOL; DOUBLE STRANDED DNA ANTIBODY; FALSE POSITIVE ANTIBODY; FAMOTIDINE; FERRITIN; GAMMA GLUTAMYLTRANSFERASE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IMMUNOGLOBULIN M ANTIBODY; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; NEUTROPHIL CYTOPLASMIC ANTIBODY; PREDNISOLONE; RHEUMATOID FACTOR; SALBUTAMOL; UNCLASSIFIED DRUG; HEPATITIS C ANTIBODY;

ABDOMINAL DISCOMFORT; ACUTE HEPATITIS A; ADULT; ANOREXIA; ANTIBODY PRODUCTION; ANTIBODY TITER; ARTHRALGIA; AUTOIMMUNE HEPATITIS; CASE REPORT; DRUG DOSE INCREASE; DRUG WITHDRAWAL; FEMALE; FEVER; HEPATOMEGALY; HUMAN; JAUNDICE; LETTER; LIVER FUNCTION TEST; MEDICAL HISTORY; MIDDLE AGED; MOUTH ULCER; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RASH; SCLERITIS; SYNOVITIS; BLOOD; HEPATITIS C; LABORATORY DIAGNOSIS;

FALSE POSITIVE REACTIONS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS;

EID: 84959933679     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiv417     Document Type: Letter

References (9)

1. Sakiani S, Koh C, Heller T. Understanding the presence of false-positive antibodies in acute hepatitis. J Infect Dis 2014; 210:1886-9.
2. Woods CR. False-positive results for Immunoglobulin M Serologic Results: Explanations and Examples. J Ped Infect Dis 2013; 2:87-90.
3. Post JJ, Chan MK, Whybin LR, et al. Positive Epstein-Barr virus and cytomegalovirus IgM assays in primary HIV infection. J Med Virol 2011; 83:1406-9.
4. Centers for Disease Control and Prevention. Positive test results for acute hepatitis Avirus infection among persons with no recent history of acute hepatitis- United States, 2002-2004. MMWR Morb Mortal Wkly Rep 2005; 54:453-6.
5. Björnsson ES, Gunnarsson BL, Gröndal G, et al. Risk of drug-induced liver injury from tumor necrosis factor antagonists. Clin Gastroenterol Hepatol 2015; 13:602-8.
6. Mancini S, Amorotti E, Vecchio S, Ponz de Leon M, Roncucci L. Infliximab-related hepatitis: discussion of a case and review of the literature. Intern Emerg Med 2010; 5:193-200.
7. Garcia-Planella E, Domenech E, Esteve-Comas M, et al. Development of antinuclear antibodies and its clinical impact in patients with Crohn's disease treated with chimeric monoclonal anti-TNFalpha antibodies (infliximab). Eur J Gastroenterol Hepatol 2003; 15:351-4.
8. Riad H, Shaikha SA, Ansari HA, Naama KA, Sada HAMansoori MA. Hepatitis and Lupus-Like Syndrome during Infliximab Therapy for Psoriasis. Case Rep Dermatol 2013; 5:219-24.
9. Alatoom A, Ansari MQ, Cuthbert J. Multiple factors contribute to positive results for hepatitis A virus immunoglobulin M antibody. Arch Pathol Lab Med 2013; 137:90-5.